#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	19096	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2539	915.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1702	1702	C	1117	C,G	1116,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	19096	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2539	915.3	0	HET	.	.	.	G1158A,T	.	1158	1158	G	1676	1676	G	1115	G,A,T	837,277,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31638	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3931	1001.9	0	.	n	.	0	T695C	SNP	695	695	T	1247	1247	C	1192	C	1192	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31638	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3931	1001.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1889	1889	A	1375	A,C	1374,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31638	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3931	1001.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2523	2523	C	1084	C,T,A	1079,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31638	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3931	1001.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3149	3149	T	1099	T,C,G,A	835,262,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31638	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3931	1001.9	0	.	n	.	0	G2872A	SNP	2872	2872	G	3424	3424	A	1183	A,G,T,C	602,579,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31638	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3931	1001.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2597	2597	A	1005	A,G,T,C	1002,1,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2818	folP	852	852	100.0	folP.l15.c4.ctg.1	2000	175.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1255	1257	AGC	267;269;266	A,C;G,T;C	265,2;268,1;266	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6698	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3980	209.9	1	SNP	p	S91F	0	.	.	271	273	TCC	798	800	TCC	252;250;250	T,C;C;C	251,1;250;250	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6698	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3980	209.9	1	SNP	p	D95N	0	.	.	283	285	GAC	810	812	GAC	255;255;257	G;A,G,C;C	255;253,1,1;257	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6698	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3980	209.9	1	SNP	p	D95G	0	.	.	283	285	GAC	810	812	GAC	255;255;257	G;A,G,C;C	255;253,1,1;257	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2656	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1760	187.8	1	SNP	p	G45D	1	.	.	133	135	GAC	663	665	GAC	339;340;340	G;A,G;C	339;339,1;340	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1454	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1571	115.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6820	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3487	244.0	1	SNP	p	D86N	0	.	.	256	258	GAC	816	818	GAC	298;302;303	G,T;A,C;C	296,2;301,1;303	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6820	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3487	244.0	1	SNP	p	S87W	0	.	.	259	261	AGT	819	821	AGT	304;303;306	A,G;G,T;T	303,1;302,1;306	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6820	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3487	244.0	1	SNP	p	S87R	0	.	.	259	261	AGT	819	821	AGT	304;303;306	A,G;G,T;T	303,1;302,1;306	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6820	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3487	244.0	1	SNP	p	S87I	0	.	.	259	261	AGT	819	821	AGT	304;303;306	A,G;G,T;T	303,1;302,1;306	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6820	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3487	244.0	1	SNP	p	S88P	0	.	.	262	264	TCC	822	824	TCC	306;304;306	T,C;C;C	305,1;304;306	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5570	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3123	222.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1850	1852	GGC	309;311;308	G,A;G,T;C	308,1;309,2;308	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1586	1588	GCA	308;310;311	G;C,A;A,C	308;309,1;310,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1589	1591	ATC	311;311;311	A,C;T,A;C	310,1;310,1;311	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1601	1603	GTG	313;318;322	G;T;G	313;318;322	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1601	1603	GTG	313;318;322	G;T;G	313;318;322	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2105	2107	ACC	294;293;299	A,C;C;C	293,1;293;299	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2159	2161	GCG	289;287;288	G;C;G	289;287;288	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2159	2161	GCG	289;287;288	G;C;G	289;287;288	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2282	2284	GGC	263;266;265	G;G,C;C,G	263;265,1;264,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2291	2293	GGC	268;269;272	G;G,T;C	268;267,2;272	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	5088	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	214.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2309	2311	CCG	279;281;278	C,G;C;GCCC,GCC	278,1;281;267,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	7112	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3582	247.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1850	1852	CTG	282;283;285	C,A;T,G;G,T,A	280,2;282,1;282,2,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3480	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2296	188.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	812	812	C	246	C	246	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	550	552	GGA	313;313;314	G;G,A,T;A	312;310,1,1;314	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	V75I	NONSYN	223	225	GTT	631	633	ATT	309;305;306	A,G;T;T	308,1;305;306	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	673	675	AGC	291;289;292	A,G,C;G;C	289,1,1;289;292	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	V98I	NONSYN	292	294	GTC	700	702	ATC	281;281;281	A;T,G,A;C,T	281;279,1,1;280,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	765	766	CG	266;266	C;G	266;266	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	768	770	CAG	268;268;271	C,T,A;A;G	266,1,1;268;271	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	772	774	AAA	271;270;270	A;A;A	271;270;270	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	799	801	TAT	286;283;281	T;A,C;T,G	286;282,1;280,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	N134E	NONSYN	400	402	AAT	808	810	GAG	279;278;279	G;A;G	279;278;279	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	V135L	NONSYN	403	405	GTG	811	813	CTT	279;282;282	C;T,C;T	279;281,1;282	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	826	828	AAA	287;286;287	A,T;A;A	286,1;286;287	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	835	837	GAA	283;287;282	G,A;A;A,C	282,1;287;281,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	859	861	GCA	281;279;282	G,A,T;C;A,C	279,1,1;279;281,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1045	1047	TCA	314;312;316	T;C,A;A,C,G	314;311,1;313,2,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1165	1167	CAA	260;258;255	C;A;A,C	260;258;254,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	.	INDELS	760	761	AC	1169	1172	ATCG	252;253;250;243	A;T,G;C;G	252;252,1;250;243	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	.	INDELS	763	764	TG	1175	1178	TAGT	239;240;239;237	T;A;G;T	239;240;239;237	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1183	1185	GAT	246;244;246	G;A;T	246;244;246	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1291	1293	AGT	285;287;287	A;G,A;T	285;286,1;287	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1297	1299	GAC	298;300;301	G;A;C	298;300;301	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1300	1302	TAC	301;302;305	T;A;C	301;302;305	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	1	SNP	p	G120K	1	.	.	358	360	AAG	765	767	CGG	266;266;267	C;G;G	266;266;267	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	1	SNP	p	A121D	1	.	.	361	363	GAC	768	771	CGC	268;271;272	C,T,A;G;C	266,1,1;271;272	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3318	porB1b	1041	1041	96.47	porB1b.l15.c17.ctg.1	1715	237.9	1	SNP	p	D121N	0	.	.	361	363	GAC	768	771	CGC	268;271;272	C,T,A;G;C	266,1,1;271;272	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	338	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	68.6	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	90;90;90	A;C;T,G	90;90;89,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	338	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	68.6	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	90;90;90	A;G,A;T	90;89,1;90	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	338	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	68.6	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	90;90;90	G;A;C	90;90;90	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	338	porB3	990	162	93.83	porB3.l15.c30.ctg.2	164	68.6	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	90;90;90	T;A;C	90;90;90	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11856	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	5259	280.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2252	2254	AAT	309;309;312	A;A;T,C	309;309;311,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1780	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1528	145.3	1	SNP	p	V57M	1	.	.	169	171	ATG	789	791	ATG	314;316;312	A;T;G,T	314;316;311,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
